title: Modification of glucose import capacity in Escherichia coli: physiologic consequences and utility for improving DNA vaccine production.
abstract: BACKGROUND
  The bacterium Escherichia coli can be grown employing various carbohydrates as sole carbon and energy source. Among them, glucose affords the highest growth rate. This sugar is nowadays widely employed as raw material in industrial fermentations. When E. coli grows in a medium containing non-limiting concentrations of glucose, a metabolic imbalance occurs whose main consequence is acetate secretion. The production of this toxic organic acid reduces strain productivity and viability. Solutions to this problem include reducing glucose concentration by substrate feeding strategies or the generation of mutant strains with impaired glucose import capacity. In this work, a collection of E. coli strains with inactive genes encoding proteins involved in glucose transport where generated to determine the effects of reduced glucose import capacity on growth rate, biomass yield, acetate and production of an experimental plasmid DNA vaccine (pHN).
  
  
  RESULTS
  A group of 15 isogenic derivatives of E. coli W3110 were generated with single and multiple deletions of genes encoding glucose, mannose, beta-glucoside, maltose and N-acetylglucosamine components of the phosphoenolpyruvate:sugar phosphotransferase system (PTS), as well as the galactose symporter and the Mgl galactose/glucose ABC transporter. These strains were characterized by growing them in mineral salts medium supplemented with 2.5 g/L glucose. Maximum specific rates of glucose consumption (qs) spanning from 1.33 to 0.32 g/g h were displayed by the group of mutants and W3110, which resulted in specific growth rates ranging from 0.65-0.18 h(-1). Acetate accumulation was reduced or abolished in cultures with all mutant strains. W3110 and five selected mutant derivatives were transformed with pHN. A 3.2-fold increase in pHN yield on biomass was observed in cultures of a mutant strain with deletion of genes encoding the glucose and mannose PTS components, as well as Mgl.
  
  
  CONCLUSIONS
  The group of E. coli mutants generated in this study displayed a reduction or elimination of overflow metabolism and a linear correlation between qs and the maximum specific growth rate as well as the acetate production rate. By comparing DNA vaccine production parameters among some of these mutants, it was possible to identify a near-optimal glucose import rate value for this particular application. The strains employed in this study should be a useful resource for studying the effects of different predefined qs values on production capacity for various biotechnological products.
authors: Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.
authors: Laura G
authors: LG
authors: Fuentes
authors: Alvaro R
authors: AR
authors: Lara
authors: Luz M
authors: LM
authors: Martínez
authors: Octavio T
authors: OT
authors: Ramírez
authors: Alfredo
authors: A
authors: Martínez
authors: Francisco
authors: F
authors: Bolívar
authors: Guillermo
authors: G
authors: Gosset
mesh_terms: D019342:Acetic Acid / Q000378:metabolism; D018533:Biomass; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004926:Escherichia coli / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D051246:Glucose Transport Proteins, Facilitative / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D009004:Monosaccharide Transport Proteins / Q000235:genetics / Q000378:metabolism; D033902:Periplasmic Binding Proteins / Q000235:genetics / Q000378:metabolism; D010731:Phosphoenolpyruvate Sugar Phosphotransferase System / Q000235:genetics / Q000378:metabolism; D010957:Plasmids / Q000235:genetics / Q000378:metabolism; D019444:Vaccines, DNA / Q000096:biosynthesis*
chemical_list: D002135:Calcium-Binding Proteins; D029968:Escherichia coli Proteins; D051246:Glucose Transport Proteins, Facilitative; D009004:Monosaccharide Transport Proteins; D033902:Periplasmic Binding Proteins; D019444:Vaccines, DNA; C023550:galactose-binding protein; D010731:Phosphoenolpyruvate Sugar Phosphotransferase System; D005947:Glucose; D019342:Acetic Acid
references: Microb Cell Fact. 2011 May 17;10:35
references: 21586123
references: J Bacteriol. 2012 Nov;194(21):5897-908
references: 22923596
references: Metab Eng. 2005 Mar;7(2):70-87
references: 15781417
references: Bacteriol Rev. 1972 Dec;36(4):525-57
references: 4568763
references: Biotechnol Bioeng. 1990 Oct 5;36(7):750-8
references: 18597268
references: Virol J. 2010 Aug 20;7:195
references: 20727167
references: Biotechnol Bioeng. 1992 Mar 15;39(6):663-71
references: 18600996
references: J Biol Chem. 1997 Jun 13;272(24):15189-99
references: 9182541
references: J Biotechnol. 2012 Apr 30;158(4):211-4
references: 21718724
references: Biotechnol Bioeng. 1996 Feb 20;49(4):421-8
references: 18623597
references: Biotechnol Prog. 1997 Jul-Aug;13(4):361-7
references: 9265774
references: J Bacteriol. 1999 Nov;181(21):6679-88
references: 10542169
references: Metab Eng. 2006 May;8(3):281-90
references: 16517196
references: FEMS Microbiol Rev. 2003 Dec;27(5):559-92
references: 14638413
references: J Bacteriol. 1975 Jun;122(3):1189-99
references: 1097393
references: Microbiology (Reading). 2005 Mar;151(Pt 3):693-706
references: 15758216
references: Bioprocess Biosyst Eng. 2008 Jan;31(1):11-20
references: 17899203
references: Metab Eng. 1999 Jan;1(1):26-34
references: 10935752
references: Biotechnol Prog. 1994 Nov-Dec;10(6):644-7
references: 7765699
references: Microb Cell Fact. 2012 Sep 19;11:132
references: 22992433
references: Mol Syst Biol. 2006;2:2006.0008
references: 16738554
references: Biotechnol Bioeng. 2005 Apr 20;90(2):191-200
references: 15759256
references: J Mol Microbiol Biotechnol. 2001 Jul;3(3):329-46
references: 11361063
references: J Bacteriol. 2004 Oct;186(20):6915-27
references: 15466045
references: BMC Syst Biol. 2011 Jul 05;5:106
references: 21726468
references: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
references: 10829079
references: J Bacteriol. 1994 Aug;176(16):5101-7
references: 8051023
references: Microb Cell Fact. 2012 Sep 13;11:127
references: 22973998
references: Appl Biochem Biotechnol. 1993 Jan-Feb;38(1-2):105-40
references: 8346901
references: Methods Mol Biol. 2012;824:271-303
references: 22160904
references: BMC Syst Biol. 2010 Dec 01;4:166
references: 21122111
references: Biotechnol Adv. 2009 Jul-Aug;27(4):353-70
references: 19233255
references: Biotechnol Bioeng. 1990 Mar 25;35(7):732-8
references: 18592570
references: Biochemistry. 1983 Dec 20;22(26):6163-70
references: 6362721